the National Natural Science Foundation for Distinguished Young Scholars of China(Grant No.82125004);the Shenzhen Science and Technology Innovation Commission(Grant No.JCYJ20220818103414030);the National Natural Science Foundation of China(Grant No.82300397);the key project of Shenzhen Basic Research Program(Natural Science Foundation of Shenzhen,Grant No.20220241);the Program for Guangdong Introducing Innovative and Enterpreneurial Teams(Grant No.2019ZT08Y481).
This study aimed to determine the prevalence and clinical features of Arrhythmogenic Right Ventricular Cardiomyopathy(ARVC)caused by pathogenic mutations in the Phospholamban(PLN)gene.The study included 170 patients w...